Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo Lira

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
ACS Medicinal Chemistry Letters|November 20, 2024
Cyclic Peptide C5aR1 Antagonist Design Using Solution Conformational Analysis Derived from Residual Dipolar CouplingsKathleen A Farley, Ye Che, Ricardo Lira, et al.
Ciencia & Saude Coletiva|January 19, 2022
Physical Education and psychosocial care: reflections about interventions in CAPS and other urban spacesRoberto Pereira Furtado, Marcos Flávio Mércio de Oliveira, Patrícia Santiago Vieira, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymeraseRicardo Lira, Alan X Xiang, Thomas Doundoulakis, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Journal of Medicinal Chemistry|February 20, 2015
Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug designChristopher R Butler, Michael A Brodney, Elizabeth M Beck, et al.
Organic Process Research & Development|August 8, 2023
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19Christophe Allais, David Bernhardson, Adam R Brown, et al.
Journal of Medicinal Chemistry|March 18, 2015
Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitorsMichael A Brodney, Elizabeth M Beck, Christopher R Butler, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ACS Medicinal Chemistry Letters|November 20, 2024
Cyclic Peptide C5aR1 Antagonist Design Using Solution Conformational Analysis Derived from Residual Dipolar CouplingsKathleen A Farley, Ye Che, Ricardo Lira, et al.
Ciencia & Saude Coletiva|January 19, 2022
Physical Education and psychosocial care: reflections about interventions in CAPS and other urban spacesRoberto Pereira Furtado, Marcos Flávio Mércio de Oliveira, Patrícia Santiago Vieira, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2007
Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymeraseRicardo Lira, Alan X Xiang, Thomas Doundoulakis, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2012
Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulatorsMartin Pettersson, Douglas S Johnson, Chakrapani Subramanyam, et al.
Journal of Medicinal Chemistry|February 20, 2015
Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug designChristopher R Butler, Michael A Brodney, Elizabeth M Beck, et al.
Organic Process Research & Development|August 8, 2023
Early Clinical Development of Lufotrelvir as a Potential Therapy for COVID-19Christophe Allais, David Bernhardson, Adam R Brown, et al.
Journal of Medicinal Chemistry|March 18, 2015
Utilizing structures of CYP2D6 and BACE1 complexes to reduce risk of drug-drug interactions with a novel series of centrally efficacious BACE1 inhibitorsMichael A Brodney, Elizabeth M Beck, Christopher R Butler, et al.
Pageof 3